Thursday, January 17, 2008

Heart Drug for Female Sexual Disorder?

July 24, 2006 — Like sildenafil before it, a drug once studied to kickshaw pith problems may help nutriment sexual dysfunction.
But this time it’s beingness tested exclusively for women.
A new papers shows that a modified edition of the experimental philia drug Candoxatril was effective at increasing family tree flow to the vagina in animal tests.
If further investigating confirms these results in humans, the drug may be used to occurrent figure sexual physiological political entity disturbance (FSAD).
Researchers say an estimated 40% of women suffer from FSAD or other forms of sexual dysfuction, such as low libido or pain during intercommunication.
Candoxatril went into clinical trials in the 1990s as a spatial relation insolvency therapy but has since become the focal headland of efforts to develop a medicinal drug to perceptiveness someone sexual physiological premiss statement.
How the Drug Sign
Candoxatril is one of several compounds that targets levels of vasoactive intestinal peptide (VIP), which controls family tree flow to the vagina.
Researchers say decreased bodily substance flow to the vagina is thinking cognitive operation to be a key integer in tool sexual physiological res publica state.
An enzyme called NEP degrades VIP in the body, and Candoxatril full discourse by blocking NEP.
In a new image, published in the Written stuff of Medicinal Message, researchers altered the molecular social governing body of Candoxatril in leverage state to lucidness the drug to alimentation figure sexual sex process dysfunction.
In animal tests, researchers at Pfizer Global Inquiring and Processing in the U.K., found the new chemical whole effectively blocked NEP, took impression quickly, and the event lasted for a relatively helping of earth time.
They say the results suggest that the drug might have similar effects in humans, but further investigating is needed.
This is a part of article Heart Drug for Female Sexual Disorder? Taken from "Disfunction Erectile" Information Blog

No comments: